(Q37578904)

21 August 2017

1 reference

title

New developments in HIV drug resistance (English)

1 reference

21 August 2017

0 references

Patricia A Cane

1

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

Journal of Antimicrobial Chemotherapy

21 August 2017

published in

1 reference

21 August 2017

volume

64 Suppl 1

1 reference

21 August 2017

page(s)

i37-40

1 reference

Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP258

Resistance mutations in human immunodeficiency virus type 1 integrase selected with elvitegravir confer reduced susceptibility to a wide range of integrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP258

Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP258

Molecular and Clinical Epidemiology of CXCR4‐Using HIV‐1 in a Large Population of Antiretroviral‐Naive Individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP258

Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP258

HIV-1 coreceptor use in triple-class treatment-experienced patients: baseline prevalence, correlates, and relationship to enfuvirtide response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP258

HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP258

Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP258

Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP258

Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP258

Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP258

Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP258

Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP258

New methods for the surveillance of HIV drug resistance in the resource poor world

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP258

Detection and quantification of minority HIV isolates harbouring the D30N mutation by real-time PCR amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP258

21 January 2018

Identifiers

DOI

10.1093/JAC/DKP258

1 reference

21 August 2017

1 reference